Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Psoriasis
2009 Standout
Specificity of platinum–DNA adduct repair
1999
Strand-specific Mismatch Repair in Mammalian Cells
1997 StandoutNobel
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Molecular mechanisms of drug resistance
2005
Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?
1992
Human papillomavirus type 16 in vulvar carcinoma, vulvar intraepithelial neoplasia, and associated cervical neoplasia
1991
The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*
1992
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Fine‐needle aspiration cytology in a regional head and neck cancer center: Comparison with a systematic review and meta‐analysis
2008
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
Epigenetics in Cancer
2008 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair
2002 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin
1998
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
1989
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
DNA Polymerase δ Is Required for Human Mismatch Repair in Vitro
1997 StandoutNobel
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors
2002
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
The MDM2 gene amplification database
1998
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
A Population-Based Study of Squamous Cell Vaginal Cancer: HPV and Cofactors
2002
A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
1999
Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study
1998
Phosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts
2004 StandoutNobel
Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5′-Directed Mismatch Repair
2009 StandoutNobel
Serum Vascular Endothelial Growth Factor in Epithelial Ovarian Neoplasms: Correlation with Patient Survival
1999
Luminescent and Redox-Active Polynuclear Transition Metal Complexes
1996 Standout
Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint
2004
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
1994 StandoutNature
Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing Hormone
1997 Nobel
N-Acylated glycerophospholipids and their derivatives
1990
Head and Neck Cancer
2001 Standout
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
2002
Cancer of the Ovary
2004 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Head and Neck Cancer
2020 Standout
Loss of DNA mismatch repair in acquired resistance to cisplatin.
1996
Das entz�ndliche Infiltrat bei Psoriasis vulgaris
1970
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Ovarian Cancer
2008
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
2006 Standout
Molecular Machines
1998 StandoutNobel
Molecular Architecture and Function of Polymeric Oriented Systems: Models for the Study of Organization, Surface Recognition, and Dynamics of Biomembranes
1988
Cellular and molecular pharmacology of oxaliplatin.
2002
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Orthogonal Self-Assembly of Low Molecular Weight Hydrogelators and Surfactants
2003 StandoutNobel
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Unconventional Methods for Fabricating and Patterning Nanostructures
1999 Standout
Primary Vaginal Cancer
1998
One‐Dimensional Nanostructures: Synthesis, Characterization, and Applications
2003 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Multiphoton Absorbing Materials: Molecular Designs, Characterizations, and Applications
2008 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Functional Self-Assembling Bolaamphiphilic Polydiacetylenes as Colorimetric Sensor Scaffolds
2004 StandoutNobel
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
The Role of CSF‐1 in Normal and Neoplastic Breast Physiology
1999
Polymer Vesicles
2002 StandoutScience
Works of A. Pfleiderer being referenced
Enzymhistochemische Untersuchungen am Carcinom des Corpus Uteri : eine Studie über Einfluss klinischer und pathologisch-anatomischer Faktoren auf die Enzymverteilung in einem Carcinom
1968
Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease
1997
In situ distribution of transforming growth factor α in normal human tissues and in malignant tumours of the ovary
1990
Microsatellite instability in ovarian neoplasms
1995
Assessment of a cytology grading system for head and neck masses
2003
Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas
1988
Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron
1992
Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha,myc, jun, and metallothionein in human ovarian carcinomas classification of malignant phenotypes
1993
Co‐expression of M‐CSF transcripts and protein, FMS (M‐CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary
1994
Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F)
1989
Nachweis von humaner Papilloma-Virus(HPV)-DNA in Vulvakarzinomen
1988
p53 Mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas
1995
The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer
1989
Destruction of Human Solid Tumors by Alkyl Lysophospholipids2
1980
[Histochemical studies on the carcinoma of the corpus uteri. Enzyme distribution in the infiltrating parts of the tumor].
1968
12 Tumour reduction and chemotherapy in ovarian cancer
1989
Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis.
1994
Recurrent cytogenetic aberrations in human ovarian carcinomas.
1995
Oncogene and growth factor expression in ovarian cancer
1992
Expression analysis of EGF-R and TGFa in human ovarian carcinomas.
1992
[Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
1976
Diagnosis and staging of ovarian cancer
1984
Human papillomavirus DNA in invasive carcinoma of the vagina.
1990
DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors.
1995